Health Trials

Epidemiology, Risk Factors, and Outcomes of Infections of Lower Limb MEGAprostheses

ConditionLower Limb Megaprosthetis Infection
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age14-100
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

About this trial

Retrospective, multicenter, non-profit observational study. The study will include consecutive patients who underwent lower-limb megaprosthesis implantation at the participating Centers between January 1, 2020, and June 30, 2023.

Eligibility criteria

Qualifiers

Age ≥ 14 years

Implantation of a lower-limb megaprosthesis at one of the participating centers between January 1, 2020, and June 30, 2023

At least 2 years of follow-up after megaprosthesis implantation

Signed informed consent

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

200 Participants
are grouped into 1 trial group

Sponsors and collaborators

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Lead sponsor

Source ClinicalTrials.gov